Loading company…
Watertown biotechnology company developing platelet-derived regenerative therapies for ocular surface disease.
Stellular Bio, Inc., formerly known as Platelet BioGenesis, Inc., develops platelet-derived regenerative biologic therapies for ocular surface disease. Established in 2014 and based in Watertown, Massachusetts, US, the company's recorded stage is Series B.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in